2,165
Views
19
CrossRef citations to date
0
Altmetric
Reviews

Fatty acid vesicles acting as expanding horizon for transdermal delivery

, , , &
Pages 251-260 | Received 07 Oct 2015, Accepted 12 Jan 2016, Published online: 18 Feb 2016

References

  • Agarwal R, Katare OP. 2002. Preparation and in-vitro evaluation of miconazole nitrate loaded topical liposomes. Pharm Tech. 48–60. Available at: http://www.pharmtech.com/data/artclestandard/pharmecch/462002/38265/article.pdf).
  • Ahmad N, Muhammad R, Tajuddin HA, Misran M. 2014. Effect of glycolipids on the stability and electrophoretic mobility of decanoic acid vesicles. Colloid Surf a Physicochem Eng Asp. 443:96–101.
  • Apel CL, Deamer DW, Mautner MN. 2002. Self-assembled vesicles of monocarboxylic acids and alcohols: conditions for stability and for the encapsulation of biopolymers. Biochim Biophys Acta. 1559:1–9.
  • Aungst BJ. 1989. Structure/effect studies of fatty acid isomers as skin penetration enhancers and skin irritants. Pharm Res. 6:244–247.
  • Bandyopadhyay P, Johnson M. 2007. Fatty alcohols or fatty acids as niosomal hybrid carrier: effect on vesicle size, encapsulation efficiency and in vitro dye release. Colloids Surf B Biointerfaces. 58:68–71.
  • Bouwstra JA, Honeywell-Nguyen PL. 2005. Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today Technol Today. 2:67–74.
  • Bouwstra JA, Ponec M. 2006. The skin barrier in healthy and diseased state. Biochim Biophys Acta. 1758:2080–2095.
  • Chitwood K, Etzkorn J, Cohen G. 2013. Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons. Dermatol Surg. 39:1306–1316.
  • Cistola DP, Hamilton JA, Jackson D, Small DM. 1988. Ionization and phase behavior of fatty acids in water: application of the Gibbs phase rule. Biochemistry. 27:1881–1888.
  • Cronstein BN. 1997. The mechanism of action of methotrexate. Rheum Dis Clin North Am. 23:739–755.
  • Deamer DW, Lancet D, Segre D, Ban-Eli D. 2001. The lipid world. Orig Life Evol Biosph. 31:119–145.
  • Dhillon V, Sharma S, Jain S, Sharma A, Arora S. 2011. Formulation characterization and evaluation of new topical 5-FU by drug entrapment in oleic acid vesicles. Am J Pharm Tech Res. 1:1–16.
  • Edwards K, Silvender M, Karlson G. 1995. Aggregate structure in dilute dispersions of oleic acid/sodium oleate and oleic/sodium oleate/egg phophatidylcholine. Langmuir. 11:2429–2434.
  • Ehdaie B. 2011. Enhanced Delivery of transdermal drugs through human skin with novel carriers. J Pharm Biomed Sci. 1:161–166.
  • El Maghraby GM, Williams AC, Barry BW. 2001. Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro. J Pharm Pharmacol. 53:1069–1077.
  • Elias PM. 1983. Epidermal lipids, barrier function and desquamation. J Invest Dermatol. 80:44–49.
  • Elsayed MMA, Abdallah OY, Naggar VF, Khalafallah NM. 2007. Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm. 332:1–16.
  • Gebicki JK, Hicks M. 1973. Ufasomes are stable particles surrounded by unsaturated fatty acid membranes. Nature. 243:232–234.
  • Grassi W, De Angelis R, Lamanna G, Cervini C. 1998. The clinical features of rheumatoid arthritis. Eur J Radiol. 27:S18–S24.
  • Hanczyc MM, Fujikawa SM, Szostak JW. 2003. Experimental models of primitive cellular compartments: encapsulation, growth and division. Science. 302:618–622.
  • Hargreaves WR, Deamer DW. 1978. Liposomes from ionic, single chain amphiphiles. Biochemistry. 17:3759–3768.
  • Hughes R, Carr A. 2002. A randomized, double-blind, placebo-controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee. Rheumatology. 41:279–284.
  • Knorr F, Lademann J, Patzelt A, et al. 2009. Follicular transport route-research progress and future perspectives. Eur J Pharm Biopharm. 71:173–180.
  • Kong JF, Rabkin SW. 2002. Palmitate induced cardiac apoptosis is mediated through CPT-1 but not influenced by glucose and insulin. Am J Physiol Heart Circ Physiol. 282:H717–H725.
  • Kumar L, Verma S, Bhardwaj A, Vaidya S, Vaidya B. 2014. Eradication of superficial fungal infections by conventional and novel approaches: a comprehensive review. Artif Cells Nanomed Biotechnol. 42:32–46.
  • Lopes LB, Ferreira DA, de Paula D, Garcia MT, Thomazini JA, Fantini MC, Bentley MV. 2006. Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin. Pharm Res. 1332–1342.
  • López-Pinto JM, González-Rodríguez ML, Rabasco AM. 2005. Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. Int J Pharm. 298:1–12.
  • Love WE, Bernhard JD, Bordeaux JS. 2009. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review. Arch Dermatol. 145:1431–1438.
  • Luisi PL, Rasi S, Mavelli F. 2003. Cooperative micelle binding and matrix effect in oleate vesicle formation. J Phys Chem B. 107:14068–14076.
  • Luisi PL, Walde P, Blocher M, Blochliger E. 1998. Matrix effect in the size distribution of fatty acid vesicles. J Phys Chem B. 102:10383–10390.
  • Marly EMJ, Kuijk-Meuwissen V, Mougin L, Junginger HE, Bouwstra JA. 1998. Application of vesicles to rat skin in-vivo: a confocal laser scanning microscopy study. J Control Release. 56:189–196.
  • Mittal R, Sharma A, Arora S. 2013. Ufasomes mediated cutaneous delivery of dexamethasone: formulation and evaluation of anti-inflammatory activity by carrageenin-induced rat paw edema model. J Pharm. 2013:680580.
  • Moreira TS, de Sousa VP, Pierre MB. 2010. A novel transdermal delivery system for the anti-inflammatory lumiracoxib: influence of oleic acid on in-vitro percutaneous absorption and in vivo potential cutaneous irritation. AAPS Pharm Sci Tech. 11:621–629.
  • Placensia L, Norlen L, Bagatoli LA. 2007. Direct visualization of lipid domains in human skinstratum corneum’s lipid membranes: effect of pH and temperature. Biophys J. 93:3142–3155.
  • Pohl EE, Peterson U, San J, Pohl P. 2000. Changes of intrinsic membrane potentials induced by flip-flop of long chain fatty acids. Biochemistry. 39:1834–1839.
  • Proksch E, Brandner JM, Jensen JM. 2008. The skin: an indispensable barrier. Exp Dermatol. 17:1063–1072.
  • Rendón A, Carton DG, Sot J, García-Pacios M, Montes LR, Valle M, et al. 2012. Model systems of precursor cellular membranes: longchain alcohols stabilize spontaneously formed oleic acid vesicles. Biophys J. 102:278–286.
  • Renoncourt A, Bauduin P, Nicholl E, Touraud D, Verbavatz JM, Dubois M. 2006. Spontaneous vesicle formation of an industrial single chain surfactant at acidic pH and at room temperature. Chemphyschem. 7:1892–1896.
  • Richy F, Bruyere O, Ethgen O, Cucherat M, Henrotin Y, Reginster JY. 2003. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med. 163:1514
  • Robinson BH, Walde P, Rogerson ML, Bucakm S. 2006. Kinetic studies of the interaction of fatty acids with phosphatidylcholine vesicles (liposomes). Colloids Surf B Biointerfaces. 48:24–34.
  • Ryan L, Brooks P. 1999. Disease-modifying antirheumatic drugs. Curr Opin Rheumatol. 11:161–166.
  • Sekulic A, Mangold AR, Northfelt DW, LoRusso PM. 2013. Advanced basal cell carcinoma of the skin: targeting the hedgehog pathway. Curr Opin Oncol. 25:218–223.
  • Sharma A, Arora S. 2012. Formulation and in-vitro evaluation of ufasomes for dermal administration of methotrexate. ISRN Pharm. 2012:873653.
  • Sharma A, Arora S. 2013. Dermal delivery of glucosamine sulphate: formulation, characterization and performance evaluation. World J Pharm Pharm Sci. 2:6448–6462.
  • Sinico C, Fadda AM. 2009. Vesicular carriers for dermal drug delivery. Expert Opin Drug Deliv. 6:813–825.
  • Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V. 2005. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev. 2: CD002946.
  • Verma S, Bhardwaj A, Vij M, Bajpai P, Goutam N, Kumar L. 2014. Oleic acid vesicles: a new approach for topical delivery of antifungal agent. Artif Cells Nanomed Biotechnol. 42:95–101.
  • Walde P, Morigaki K. 2007. Fatty acid vesicles. Curr Opin Colloid Interface Sci. 12:75–80.
  • Wu TP, Stein JA. 2013. Nonmelanoma skin cancer in young women. J Drugs Dermatol. 12:568–572.
  • Zakir F, Vaidya B, Goyal AK, Malik B, Vyas SP. 2010. Development and characterization of oleic acid vesicles for the topical delivery of fluconazole. Drug Deliv. 17:238–248.
  • Zakir F, Vaidya B, Malik B, Vyas SP. 2011. Fatty acid vesicles: promising drift in colloidal drug carriers. In: Vyas SP, Murthy RSR, Narang RK, Eds. Nanocolloidal Carriers: Site Specific and Controlled Drug Delivery. New Delhi: CBS publishers. pp. 201–218.
  • Zhang F, Kamp F, Hamilton JA. 1996. Dissociation of long and very long chain fatty acids from phospholipid bilayers. Biochemistry. 35:16055–16060.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.